On April 10, 2025, WEGO successfully held its 2025 Global Partner Conference in Shanghai, bringing together representatives from over 100 medical companies across more than 30 countries and regions. The conference focused on new paradigms for global expansion in the medical device industry.
Key Attendees and Highlights
The event was attended by industry leaders including Chen Ning, Committee Member of the Yangtze River Delta National Technology Innovation Center, Zhu Yinghua, Director of the Shanghai Hongqiao Business District, Peng Zheying, Director of the Shanghai Minhang District Business Committee, Ding Jianfeng, Deputy General Manager of Shanghai Nanhongqiao Investment Development Group, Tang Zhengpeng, President of WEGO Yangtze River Delta Group, and Zhang Yong, General Manager of WEGO Overseas Group.
Conference Theme: “CLOSER, TOGETHER, FUTURES”
With the theme “CLOSER, TOGETHER, FUTURES”, the conference focused on three core topics: globalization of medical devices, local production, and technological innovation & regional collaboration. A key highlight was the introduction of the “Technology-Capacity-Service” Triangle Model, which aims to shift China’s medical industry from “product export” to a full “ecosystem export”. This model integrates smart manufacturing, capital empowerment, and ecosystem collaboration to drive international growth.
At the event, WEGO, in partnership with the Shanghai Hongqiao Business District Management Committee, the Minhang District People’s Government, and the Yangtze River Delta National Technology Innovation Center, officially launched the Greater Hongqiao Medical Device Ecosystem. This ecosystem will support mutual recognition of medical device standards, cross-border R&D data sharing, and provide critical resources to help Chinese companies secure leadership in global medical technology.
The Greater Hongqiao Medical Device Ecosystem will integrate R&D, production logistics, legal compliance, and market promotion to create a seamless global expansion platform. Chen Ning emphasized that this initiative will help drive the mutual recognition of medical standards and facilitate the internationalization of Chinese SMEs. Through the “Going Global Acceleration Plan”, small and medium-sized enterprises will benefit from expedited CE/FDA certification, cross-border IP protection, and recognition of overseas clinical trial data.
WEGO’s Global Strategy Unveiled
Zhang Yong also unveiled WEGO’s global strategy, which leverages China’s “dual circulation” strategy and the Belt and Road Initiative. By 2025, WEGO plans to establish 25 strategic hubs around the world, integrating Asia, Europe, and the Americas into its global R&D network. This strategy will focus on localized operations and innovative collaborations, enhancing WEGO’s international presence.
Roundtable Discussions and Keynote Speeches
The conference featured roundtable discussions and keynote speeches focused on market entry strategies and risk management. Key discussions highlighted the importance of balancing efficiency and compliance in localized production and navigating risks such as FCPA violations and export controls. The keynote speeches emphasized WEGO’s strategy of technological breakthroughs, clinical transformations, and ecosystem collaboration, aiming for broader market penetration and greater technological accessibility.
Vision for the Future: From Participant to Rule-Maker
Tang Zhengpeng emphasized WEGO’s mission of “working together with healthcare professionals to create a healthier future”. The launch of the Greater Hongqiao Medical Device Ecosystem is aligned with China’s Belt and Road initiative, marking a significant step toward promoting “Chinese manufacturing” on the global stage. WEGO is committed to building an ecosystem of shared innovation and a global health community, with a vision to move from being a participant in global healthcare governance to a rule-maker.
WEGO Cloud Innovation and Strategic Hubs
Post-conference, guests visited the WEGO Cloud Innovation and Smart Creation Park, part of the Shanghai “1+5+X” biomedical cluster in the Hongqiao Biomedical R&D Headquarters. The park’s location offers seamless access to global markets, with connections to Europe, the US, and Southeast Asia. The park’s shared GMP workshops, cross-border R&D labs, and incubator facilities will support WEGO’s acquisitions and accelerate the internationalization of Chinese innovations.
Conclusion
The 2025 WEGO Global Partner Conference marked a pivotal moment in WEGO’s journey toward global leadership in medical device innovation. With the launch of the Greater Hongqiao Medical Device Ecosystem, WEGO is well-positioned to shape the future of global healthcare. Through continued innovation, collaboration, and strategic global expansion, WEGO is committed to contributing to a healthier, more connected world.
